Litcius/Paper detail

Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT

Nicola Polverelli, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Tiziano Barbui, Mariella D’Adda, Hans Joachim Deeg, Markus Ditschkowski, Claire Harrison, Nicolaus Kröger, Ruben A. Mesa, Francesco Passamonti, Francesca Palandri, Naveen Pemmaraju, Uday Popat, Damiano Rondelli, Alessandro M. Vannucchi, Srđan Verstovšek, Marie Robin, Antonio Colecchia, Luigi Grazioli, Enrico Damiani, Domenico Russo, J.L. Brady, David Patch, Sławomir Blamek, Gandhi Damaj, Patrick Hayden, Donal P. McLornan, Ibrahim Yakoub‐Agha

2022The Lancet Haematology43 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMyelofibrosisContraindicationTransplantationSplenectomySurgeryThrombosisInternal medicinePortal vein thrombosisSpleenPathologyBone marrowAlternative medicineMyeloproliferative Neoplasms: Diagnosis and TreatmentHemoglobinopathies and Related DisordersHematopoietic Stem Cell Transplantation
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT | Litcius